Palbociclib 75mg, 100mg, 125mg Capsules — First-in-Class CDK4/6 Inhibitor for HR-Positive HER2-Negative Advanced and Metastatic Breast Cancer in Combination With Endocrine Therapy
Abemaciclib 50mg, 100mg, 150mg Film Coated Tablets — CDK4/6 Inhibitor for HR-Positive HER2-Negative Breast Cancer in Combination With Endocrine Therapy and as Monotherapy
